Vydura 75 mg, Lyophilisat zum Einnehmen
7680690350031
CH-69035
Lyophilisat
Associated product:
VYDURA ODT cpr orodisp 75 mg 16 pce
1 / 3
google
Article details
- Package size
- 16
- Selling units
- 16
- Measure
- Einzeldose(n)
- Galenic form
- Lyophilisat
- Galenic group
- Lösbar zur Injektion/Infusion
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
rimegepantum
|
75.0 MG | Substance | Wirkstoff (Principe actif) |
|
rimegepanti hemisulfas sesquihydricus
|
- | Substance | WIZUS |
|
gelatina
|
- | Substance | HNIDK |
|
mannitolum
|
- | Substance | HNIDK |
|
sucralosum
|
- | Substance | HNIDK |
|
aromatica
|
- | Substance | AROMA |
|
alcohol benzylicus
|
- | Substance | HBESI |
Reimbursement information
Public price
CHF 377.30
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
01/05/2024
Authorization holder
Pfizer AG
8052 Zürich
Authorization information
- Swissmedic authorization number
- 69035
- Drug name
- Vydura, Lyophilisat zum Einnehmen
- Galenic form
- LYO
- ATC Code
- N02CD06
- Authorization status
- Z
- Dispensing category
- B
- First authorization
- 18/10/2023
- Authorization expiration date
- 17/10/2028
- IT Number
- 02.05.1.
- Domain
- Human medicine
Package details
- Description (FR)
- VYDURA ODT cpr orodisp 75 mg 16 pce
- Description (DE)
- VYDURA ODT Schmelztabl 75 mg 16 Stk
- Market launch
- 18/10/2023
- Narcotic (BTM)
- No